When surgeons remove a kidney tumor, they face a delicate balancing act: cut away the cancer while preserving as much of the ...

Oral cancer is one of the most common cancers linked directly to a preventable habit, and yet it continues to claim lives at ...

HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with ...

Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, ...

Multi-omic profiling stratified recurrence risk beyond pathological stage in resected EGFR-mutant lung adenocarcinoma and may refine adjuvant TKI selection.

New Data on Germline EGFR T790M and Non-Smoker Lung Cancer Risk / cancer, EGFR gene, epidermal growth factor receptor, ...

The lab number most people see first tells only half the kidney story.

Genomic testing in high-risk prostate cancer remains underutilized nationally, driven by fragmented ordering and interpretive ...

Immunome plans a Phase 1 trial of IM-1340 in advanced solid tumours in the fourth quarter of 2026 after FDA IND clearance.

Sonic Hedgehog (Shh), secreted from gastric parietal cells, contributes to the regeneration of the epithelium. The recruitment of macrophages plays a central role in the regenerative process. The ...

India needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, ...